中国住院脓毒症的国家发病率与死亡率
该研究利用全国医疗服务数据中心(NDCMS)和国家死亡监测系统(NMSS),按ICD-10编码回顾性识别2017至2019年中国住院脓毒症病例。共识别9,455,279例患者、10,682,625例次隐含编码脓毒症入院及806,728例脓毒症相关死亡。估算年标准化住院脓毒症发病率2017年为328.25/10万(95%CI 315.41-341.09)、2018年为359.26/10万(95%CI 345.4-373.12)、2019年为421.85/10万(95%CI 406.65-437.05)。发病率存在显著空间自相关,且医院床位供应量更高和人均可支配收入更高与住院脓毒症发病率更高显著相关。
要点
- 2017至2019年中国住院脓毒症年标准化发病率分别为328.25、359.26、421.85例/10万,呈逐年上升。
- 住院脓毒症发病构成:新生儿(<1岁)占8.7%,1-9岁儿童占11.7%,>65岁老年人占57.5%。
- 全国范围内住院脓毒症发病率存在显著空间自相关,2017、2018、2019年Moran's Index分别为0.42(p=0.001)、0.45(p=0.001)、0.26(p=0.011)。
- 医院床位供应量更高和人均可支配收入更高与住院脓毒症发病率更高显著相关。
- 研究共识别9,455,279例患者、10,682,625例次隐含编码脓毒症入院和806,728例脓毒症相关死亡。
适用人群与场景
- 2017至2019年中国全国范围内住院脓毒症患者,数据来自全国医疗服务数据中心(NDCMS)和国家死亡监测系统(NMSS)。
- 发病构成包括新生儿(<1岁)占8.7%、1-9岁儿童占11.7%、>65岁老年人占57.5%。
诊断标准与关键阈值
- 通过ICD-10编码回顾性识别住院脓毒症。
- 院内脓毒症病死率和死亡率用于外推全国住院脓毒症发病率。
研究设计与关键结果
- 研究类型为基于全国数据库的回顾性研究,数据时段为2017至2019年。
- 共识别9,455,279例患者、10,682,625例次隐含编码脓毒症入院(NDCMS)和806,728例脓毒症相关死亡(NMSS)。
- 年标准化住院脓毒症发病率:2017年328.25例/10万(95%CI 315.41-341.09),2018年359.26例/10万(95%CI 345.4-373.12),2019年421.85例/10万(95%CI 406.65-437.05)。
- 发病率空间自相关:2017年Moran's Index 0.42(p=0.001),2018年0.45(p=0.001),2019年0.26(p=0.011)。
- 医院床位供应量更高和人均可支配收入更高与住院脓毒症发病率更高显著相关。
证据类型、等级与局限
- 证据类型:基于全国行政数据库的回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 本研究显示中国住院脓毒症负担高于既往估计,地理分布存在差异,作者认为需要在脓毒症预防方面做出更多努力。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis is a leading cause of preventable death around the world. Population-based estimation of sepsis incidence is lacking in China. In this study, we aimed to estimate the population-based incidence and geographic variation of hospitalized sepsis in China.
METHODS: We retrospectively identified hospitalized sepsis from the nationwide National Data Center for Medical Service (NDCMS) and the National Mortality Surveillance System (NMSS) by ICD-10 codes for the period from 2017 to 2019. In-hospital sepsis case fatality and mortality rate were calculated to extrapolate the national incidence of hospitalized sepsis. The geographic distribution of hospitalized sepsis incidence was examined using Global Moran's Index.
RESULTS: We identified 9,455,279 patients with 10,682,625 implicit-coded sepsis admissions in NDCMS and 806,728 sepsis-related deaths in NMSS. We estimated that the annual standardized incidence of hospitalized sepsis was 328.25 (95% CI 315.41-341.09), 359.26 (95% CI 345.4-373.12) and 421.85 (95% CI 406.65-437.05) cases per 100,000 in 2017, 2018 and 2019, respectively. We observed 8.7% of the incidences occurred among neonates less than 1 year old, 11.7% among children aged 1-9 years, and 57.5% among elderly older than 65 years. Significant spatial autocorrelation for incidence of hospitalized sepsis was observed across China (Moran's Index 0.42, p = 0.001; 0.45, p = 0.001; 0.26, p = 0.011 for 2017, 2018, 2019, respectively). Higher number of hospital bed supply and higher disposable income per capita were significantly associated with a higher incidence of hospitalized sepsis.
CONCLUSION: Our study showed a greater burden of sepsis hospitalizations than previous estimated. The geographical disparities suggested more efforts were needed in prevention of sepsis.
参考来源
- Weng L, Xu Y, Yin P, et al. National incidence and mortality of hospitalized sepsis in China. Crit Care. 2023. PMID: 36870989. doi:10.1186/s13054-023-04385-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。